PCK painchek ltd

14.7%

3.9¢

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-20

First 20 Last

Share
Profile

Follow
nolly

1,581 Posts.

51

06/02/25

10:26

Post #: 77729873
Share

Originally posted by Screenlover: ↑

Whats truly interesting is . If this was a mining share and the mine had the potential to extract a portion of an ore load of $100 000 000.00 per year it definitely wouldn’t be a 2.6c share. Yet with relatively low overheads and the current rock samples showing great potential nobody seems to be wanting to speculate on the future.
I would have expected that an announcement that describes access to the mother load by May would have had the SP moving, but alas we are hovering . A re rate is coming, but I can’t seem to figure out why it’s not happening now.
Perhaps by next quarter the enthusiasm may increase.
I wonder if the announcement of May by PD is a date that he has been given by FDA or a speculation of 150 day average.
With all the pre submissions and back and forth correspondence, I was genuinely confident of a quicker than average approval. I had late March early April as my scenario of approval. Let’s face it, it is a medical device, but only really a Class 1. Nobody dies with a misdiagnosis from painchek. It is merely an objective tool to save time and paper, and allowing users to make informed decisions on forward treatment, with data collected in the process.
I can’t see it not being approved as it is being used already incident free and with positive outcomes.
And I can’t see it taking that long to be approved, All boxes are checked, all ethical, clinical studies support its use. What is the hold up. Get on with it FDA it’s not rocket science.
Good luck Holders.
2025 as predicted by Fatt is heating up for a big year. I agree but have been premature several times now and patience is all that required.

I think all those whom have done their research can see that this has the potential to make some serious money .
DYOR.

Expand

PCK submitted FDA on 20 Nov so 150 day to approve is around 20 April, Not May which would be 180 days. So if it comes in early it could be next month MARCH. So with all things in place with US roll out ( 2nd parties involved ) 2025 should be a Good Year.

PCK Price at posting: 2.7¢ Sentiment: Hold Disclosure: Held
2 Upvote

1 Great analysis

Reply

Top Stories

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

AII

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

First 20 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 3.9¢		Change 0.005(14.7%)		Mkt cap ! $71.84M

Open	High	Low	Value	Volume
3.7¢	4.0¢	3.7¢	$48.55K	1.271M

Buyers (Bids)

No.	Vol.	Price($)
1	83054	3.8¢

Sellers (Offers)

Price($)	Vol.	No.
3.9¢	45329	1

View Market Depth

No.	Vol.	Price($)
1	200000	0.035
4	182550	0.034
7	1082687	0.033
6	3532500	0.032
9	737217	0.031

Price($)	Vol.	No.
0.039	45329	1
0.041	1	1
0.042	160000	1
0.043	359000	3
0.045	260000	4

Last trade - 15.20pm 27/06/2025 (20 minute delay)

PCK (ASX) Chart

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-20

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Monash IVF shares cater 25% – Disaster or deep-value play?

Australia’s gas crisis is here – and dying coal plants aren’t helping

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-20

Top Stories

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Monash IVF shares cater 25% – Disaster or deep-value play?

Australia’s gas crisis is here – and dying coal plants aren’t helping

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News